en

PRODUCT DETAIL

Kymriah

Code 8935C
MA number EU/1/18/1297/001
Product Form: dis inf 1-3 (vak etylénvinylacetátový (EVA))
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
MAH, country: Novartis Europharm Limited, Ireland
Therapeutic Class: 87 - VARIA I
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XL ?
L01XL04 Tisagenlecleucel
Shelf life: 9
Container: bag ethylene vinyl acetate (EVA)
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 23.08.2018
SmPC + PL: European Medicines Agency's database
Dokument: Kymriah_Prirucka pre pacienta.pdf  
Dokument: Kymriah_Karta Pacienta.pdf  
Dokument: Kymriah_Edu_mat_lekaren_bunkove lab_inf_cen.pdf  
Dokument: Kymriah_skoliaci materiaal pre zdravotnickych pracovnikov.pdf  
Dokument: DHPC_CAR-T cells_18.07.2024.pdf  
Safety feature No
Data update: 18.05.2023
eu-flag.png sk-flag.png